Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walenga

Showing results (21-30 of 196) with videos related to

Pageof 20
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer avenues in the monitoring of antithrombotic therapy: the role of automationJ M Walenga, J Fareed, H L Messmore
Seminars in Thrombosis and Hemostasis|April 1, 1985
Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractionsD A Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1985
In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169)J M Walenga, J Fareed, D A Hoppensteadt
Seminars in Thrombosis and Hemostasis|January 1, 1991
Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparinD A Hoppensteadt, J M Walenga, J Fareed
Journal of Thrombosis and Thrombolysis|January 13, 2001
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, H L Messmore
Seminars in Thrombosis and Hemostasis|October 1, 1983
Evaluation of "Statsep," a semiautomated device to prepare plasma samples for coagulation analysisD Hoppensteadt, J M Walenga, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragmentsA Racanelli, J Fareed, J M Walenga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2000
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human bloodB Kaiser, W Jeske, J M Walenga, et al.
Thrombosis Research|May 15, 1993
Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug "defibrotide". A dual mechanism in the control of vascular pathologyP Bacher, G Kindel, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.
Pageof 20

Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer avenues in the monitoring of antithrombotic therapy: the role of automationJ M Walenga, J Fareed, H L Messmore
Seminars in Thrombosis and Hemostasis|April 1, 1985
Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractionsD A Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1985
In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169)J M Walenga, J Fareed, D A Hoppensteadt
Seminars in Thrombosis and Hemostasis|January 1, 1991
Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparinD A Hoppensteadt, J M Walenga, J Fareed
Journal of Thrombosis and Thrombolysis|January 13, 2001
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, H L Messmore
Seminars in Thrombosis and Hemostasis|October 1, 1983
Evaluation of "Statsep," a semiautomated device to prepare plasma samples for coagulation analysisD Hoppensteadt, J M Walenga, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragmentsA Racanelli, J Fareed, J M Walenga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2000
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human bloodB Kaiser, W Jeske, J M Walenga, et al.
Thrombosis Research|May 15, 1993
Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug "defibrotide". A dual mechanism in the control of vascular pathologyP Bacher, G Kindel, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.
Pageof 20